BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, March 28, 2024
Home
»
Newsletters
» BioWorld
BioWorld
April 5, 2010
View Archived Issues
Sequencing Speeds Up, But Drug Discovery Still a Slog
Read More
Biotech's Future: BioWorld Gives You 2020 Vision in 2010!
Read More
Appointments And Advancements
Read More
Vital Signs
Read More
Other News To Note
Read More
Financings Roundup
Read More
Clinic Roundup
Read More
Bench Press
Read More
Salix Liver-Failure Win Puts Spotlight on Xifaxan in IBS
Salix Pharmaceuticals Inc.'s path forward should become clear shortly with the approved antibiotic Xifaxan in its third potential, and much-coveted, indication: irritable bowel syndrome. (BioWorld Today)
Read More
New NYU Stem Cell Lines Boost NIH Registry to 51
Read More